Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo
AbstractIn this review, we discuss how cell-penetrating peptides (CPPs) might get access to their intracellular targets. We specifically focus on the challenge of deciding whether the positively-charged CPPs are just bound to the negatively-charged cell surface and subsequently endocytosed or actually transported into the cytosol, either by direct plasma membrane penetration or after endocytosis. This discussion includes comments about pitfalls when using pharmacological inhibitors in such studies. The possibility of exploiting CPPs as carriers for the delivery of drugs of different sizes in vitro is discussed, as is the use of CPPs as carriers for therapeutic drugs or contrast agents in vivo. We conclude that in many cases, more studies are needed to demonstrate conclusively whether increased delivery of a substance attached to CPPs is due to a membrane-penetrating property or whether the increase is a consequence of just changing the charge of the substance to be delivered. Finally, the expected dose needed for the use of such conjugates in vivo is discussed, including aspects to consider in order to bring potential products into clinical use. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Skotland, T.; Iversen, T.G.; Torgersen, M.L.; Sandvig, K. Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo. Molecules 2015, 20, 13313-13323.
Skotland T, Iversen TG, Torgersen ML, Sandvig K. Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo. Molecules. 2015; 20(7):13313-13323.Chicago/Turabian Style
Skotland, Tore; Iversen, Tore G.; Torgersen, Maria L.; Sandvig, Kirsten. 2015. "Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo." Molecules 20, no. 7: 13313-13323.